New study identifies biological mechanism driving therapy resistance in advanced prostate cancer

The Medical News ·
Health & Medicine United Kingdom

A multi-institutional collaborative study led by researchers at the University of Chicago and the Fred Hutchinson Cancer Center has identified a previously unknown biological mechanism that controls cell identity and treatment resistance in advanced prostate cancer.

Read original article on The Medical News →

Related news